PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30971955-11	2019	Treatment with gliclazide 10 mg/kg reduced MPO activity (p < 0.001), MDA levels (p < 0.001) and NFkappaB NLS P50 (p < 0.05) protein levels, resulting in low immunostaining to Cox-2, iNOS (p < 0.05), NFkappaB P65 (p < 0.05), and negative immunoreaction to MMP-2 (p < 0.001).	Gliclazide	15-25	myeloperoxidase	Homo sapiens	43-46	
32045587-9	2020	Gliclazide (10 mg/kg; p.o) prominently decreased colon tissue injury as assessed by the histopathological analysis, myeloperoxidase, and intercellular adhesion molecule-1 levels.	Gliclazide	0-10	myeloperoxidase	Homo sapiens	116-170